Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
07 2019
Historique:
received: 23 01 2018
accepted: 01 04 2019
pubmed: 1 5 2019
medline: 24 3 2020
entrez: 1 5 2019
Statut: ppublish

Résumé

To assess treatment satisfaction and the effectiveness of a flash glucose monitoring (FGM) system in patients with type 2 diabetes using insulin. A total of 101 patients with type 2 diabetes on multiple daily insulin injections (MDI) for at least 1 year were assigned randomly to the FGM intervention ( The intervention group found treatment significantly more flexible ( FGM tends to improve treatment satisfaction and may lead to amelioration of glycemic control in patients with type 2 diabetes on MDI without increasing the frequency of hypoglycemia.

Identifiants

pubmed: 31036546
pii: dc18-0166
doi: 10.2337/dc18-0166
doi:

Substances chimiques

Blood Glucose 0
Glycated Hemoglobin A 0
Hypoglycemic Agents 0
Insulin 0
Glucose IY9XDZ35W2

Banques de données

ClinicalTrials.gov
['NCT02809365']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1178-1184

Informations de copyright

© 2019 by the American Diabetes Association.

Auteurs

Marianna Yaron (M)

Diabetes Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Eytan Roitman (E)

Diabetes Medical Center, Tel Aviv, Israel.

Genya Aharon-Hananel (G)

Diabetes Medical Center, Tel Aviv, Israel.

Zohar Landau (Z)

Diabetes Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Diabetes Unit, E. Wolfson Medical Center, Holon, Israel.

Tali Ganz (T)

Diabetes Unit, E. Wolfson Medical Center, Holon, Israel.

Ilan Yanuv (I)

Hebrew University, Jerusalem, Israel.

Aliza Rozenberg (A)

Hebrew University, Jerusalem, Israel.

Moshe Karp (M)

Diabetes Medical Center, Tel Aviv, Israel.

Maya Ish-Shalom (M)

Diabetes Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Joelle Singer (J)

Diabetes Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Julio Wainstein (J)

Diabetes Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Diabetes Unit, E. Wolfson Medical Center, Holon, Israel.

Itamar Raz (I)

Diabetes Medical Center, Tel Aviv, Israel ntv502@netvision.net.il.
Hebrew University, Jerusalem, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH